The Discounted Cash Flow (DCF) valuation of Samrat Pharmachem Ltd (530125.BO) is 399.31 INR. With the latest stock price at 370.00 INR, the upside of Samrat Pharmachem Ltd based on DCF is 7.9%.
Based on the latest price of 370.00 INR and our DCF valuation, Samrat Pharmachem Ltd (530125.BO) is a buy. buying 530125.BO stocks now will result in a potential gain of 7.9%.
| Range | Selected | |
| WACC / Discount Rate | 13.1% - 16.2% | 14.7% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 333.66 - 497.91 | 399.31 |
| Upside | -9.8% - 34.6% | 7.9% |